A Conversation with Eli Lilly CEO Dave Ricks: Navigating the Global Future of Healthcare

The latest episode of T. Rowe Price’s “The Angle” podcast features a discussion between Eric Veiel and Eli Lilly CEO Dave Ricks on chronic disease management, leadership, and global healthcare challenges. Ricks provides insights into healthcare’s future, particularly regarding innovations in areas like diabetes, cancer, Alzheimer’s, and weight loss drugs. The podcast, part of a C-suite series, aims to offer dynamic perspectives on market trends and connects macroeconomic forces with corporate strategy. “The Angle” is one of two podcasts by T. Rowe Price, which manages $1.79 trillion in assets.

“`html

The latest episode of T. Rowe Price’s “The Angle,” a podcast series focusing on investment strategies and market trends, is now available. The episode features a conversation between Eric Veiel, Head of Global Investments and Chief Investment Officer for T. Rowe Price, and Dave Ricks, Chair and CEO of Eli Lilly and Company, a major player in the pharmaceutical industry.

The discussion delves into the rapidly changing landscape of chronic disease management, the critical role of purpose-driven leadership, and the multifaceted challenges and opportunities confronting the global healthcare sector. Ricks, leading a company renowned for its innovations in diabetes, cancer, and Alzheimer’s disease treatments, and increasingly, in the burgeoning weight loss drug market, offers valuable insights into the future of healthcare.

“Dave Ricks provides a unique perspective on the future of healthcare,” said Veiel. “His insights into innovation, leadership, and the complexities of ensuring access to life-changing medicines are particularly relevant in today’s environment. His dedication to addressing the most pressing medical challenges and his vision for improving health outcomes on a global scale offer important lessons for both leaders and investors.”

This episode marks the ninth installment in T. Rowe Price’s C-suite podcast series. Previous episodes have featured prominent leaders such as H. Lawrence Culp, Jr. of GE Aerospace, Meredith Kopit Levien of The New York Times Company, Gary Guthart of Intuitive Surgical, Jensen Huang of NVIDIA Corporation, Darren Woods of ExxonMobil, Harvey Schwartz and David Rubenstein of Carlyle, Jane Fraser of Citi, and Sarah Friar of OpenAI.

“The Angle” aims to provide listeners with dynamic insights into the forces reshaping financial markets. The podcast features the T. Rowe Price global investing team and prominent guest speakers to foster a deeper understanding of today’s evolving market themes.

Since its launch in 2024, “The Angle” has explored various critical topics, including the “blue economy,” the impact of artificial intelligence, the 2024 U.S. election, forward-looking perspectives on global markets, and key market drivers as seen through the eyes of leading CEOs. The series exemplifies T. Rowe Price’s commitment to providing sophisticated investment analysis and thought leadership. By engaging with top executives, the podcast offers a crucial link between macroeconomic trends and corporate strategy, providing listeners with a clearer understanding of the forces shaping investment decisions.

“The Angle” is the second podcast produced by T. Rowe Price, in addition to “CONFIDENT CONVERSATIONS® on Retirement,”.

T. Rowe Price, a leading global asset management firm, manages approximately $1.79 trillion in client assets as of October 31, 2025. The firm is recognized for its investment expertise, retirement leadership, and independent research capabilities. Built on a culture of integrity and client focus, T. Rowe Price seeks to empower investors to thrive in ever changing market conditions.

“`

Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/13172.html

Like (0)
Previous 2025年12月24日 pm8:51
Next 2025年12月24日 pm9:08

Related News